Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)

NCT05181969 · clinicaltrials.gov ↗

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Lipoproteinemia
Apheresis Related Complication
Cardiovascular Diseases

Interventions

DEVICE: Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
DEVICE: Lipid filtration (Octo Nova®, Diamed Medizintechnik)
DEVICE: Direct absorption of lipoproteins (DALI®; ADS 4008, Fresenius)
DEVICE: Therasorb (TheraSorb® - LDL adsorbers, Miltenyi Biotec)

Sponsor

Technische Universität Dresden